Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TPN1: Intralipid vs ClinOleic in Healthy Volunteers
NCT02185729Phase 3
Key facts
- Status
- Completed
- Start
- Jun 2008
- Primary completion
- Mar 2012
- Countries
- 1
- Sponsor
- Emory University
- Modality
- Liposomes, Small Molecules
- Conditions
- Malnutrition
01
Overview
Phase 3, randomised trial of Clinoleic and Intralipid 10% in Malnutrition, sponsored by Emory University. Primary endpoint: Flow Mediated Dilation at 24 hours. Started Jun 2008; status: completed.
02
Design
- Study design
- Randomized
03
Who it enrols
Healthy volunteers with BMI 25-35 kg/m2, aged 18-65, without history of diabetes, hypertension, or significant liver/kidney disease.
04
Endpoints
Primary
Flow Mediated Dilation
Beyond the preview
Go deeper on NCT02185729.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02185729.